Jagsonpal Pharmaceuticals Limited
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Jagsonpal Pharmaceuticals Limited's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8% to $2,087,020,000. The net income raised on $224,630,000 and profit margin reached 11%. Total operating expenses were $438,550,000.
Profit Margin
| 2010 | 1.39B | 92.41M | 6.62% |
|---|---|---|---|
| 2011 | 1.60B | 71.79M | 4.46% |
| 2012 | 1.76B | 74.56M | 4.22% |
| 2015 | 1.38B | 11.71M | 0.85% |
| 2016 | 1.43B | 32.54M | 2.27% |
| 2018 | 1.26B | -115.50M | -9.13% |
| 2019 | 1.66B | 72.16M | 4.33% |
| 2021 | 1.87B | 170.58M | 9.08% |
| 2022 | 2.26B | 188.55M | 8.34% |
| 2024 | 2.08B | 224.63M | 10.76% |
JAGSNPHARM.NS Income Statement (2010 – 2023)
| 2023 | 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.08B | 2.26B | 1.87B | 1.66B | 1.26B | 1.43B | 1.38B | 1.76B | 1.60B | 1.39B |
Cost of revenue | 1.43B | 961.05M | 809.34M | 729.32M | 612.94M | 591.23M | 686.82M | 845.45M | 830.00M | 755.02M |
Gross profit | 652.59M | 1.29B | 1.06B | 938.93M | 652.38M | 843.64M | 694.68M | 919.68M | 779.54M | 640.91M |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 3.45M | 1.20M | 3.74M | 4.68M | 3.28M | 0 | 0 | 0 |
Selling and marketing | 163.36M | 153.17M | 129.90M | 131.97M | 112.45M | 109.95M | 0 | 0 | 0 | 0 |
Total operating expenses | 438.55M | 1.05B | 881.55M | 854.42M | 765.44M | 750.56M | 633.37M | 778.89M | 653.64M | 500.94M |
Operating income | 214.04M | 239.87M | 187.86M | 83.19M | -111.26M | 40.75M | 16.71M | 140.78M | 125.89M | 139.96M |
Other income (expenses), net | 84.65M | 26.55M | 30.85M | 6.83M | -3.20M | -52.33M | -44.45M | -39.89M | 33.21M | 34.96M |
Income before tax | 298.69M | 273.19M | 218.72M | 90.02M | -116.26M | 40.75M | 16.71M | 100.89M | 92.68M | 105.00M |
Income tax expense | 74.06M | 77.32M | 48.14M | 17.86M | -761K | 8.21M | 5.00M | 26.33M | 20.88M | 12.58M |
Net income | 224.63M | 188.55M | 170.58M | 72.16M | -115.50M | 32.54M | 11.71M | 74.56M | 71.79M | 92.41M |
Earnings per share | ||||||||||
Basic EPS | 8.49 | 7.2 | 6.51 | 2.75 | -4.41 | 1.24 | 0.45 | 2.85 | 2.74 | 3.53 |
Diluted EPS | 8.46 | 7.2 | 6.51 | 2.75 | -4.41 | 1.24 | 0.45 | 2.85 | 2.74 | 3.53 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |